These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6210423)

  • 21. The action of a dopamine (DA1) receptor agonist, fenoldopam in human vasculature in vivo and in vitro.
    Hughes A; Thom S; Martin G; Redman D; Hasan S; Sever P
    Br J Clin Pharmacol; 1986 Nov; 22(5):535-40. PubMed ID: 2878679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of dopamine receptor agonists on the cAMP content in arteries of the rabbit.
    Zhu L; Zhao RR; Zhang WF
    Sheng Li Xue Bao; 2000 Jun; 52(3):247-51. PubMed ID: 11956574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-adrenoceptor blocking activity of fenoldopam (SK&F 82526), a selective DA1 agonist.
    Nakamura S; Kohli JD; Rajfer SI
    J Pharm Pharmacol; 1986 Feb; 38(2):113-7. PubMed ID: 2870153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relative DA1-dopamine-receptor agonist and alpha-adrenoceptor antagonist activity of fenoldopam in the anesthetized dog.
    Kohli JD; Glock D; Goldberg LI
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):123-6. PubMed ID: 2450250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical and pharmacological characterization of ganglionic dopamine receptors.
    Sabouni MH; Alkadhi KA; Lokhandwala MF
    Clin Exp Hypertens A; 1987; 9(5-6):873-87. PubMed ID: 2887312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurons from substantia nigra increase the efficacy and potency of second messenger arising from striatal astroglia dopamine receptor.
    Hansson E; Rönnbäck L
    Glia; 1988; 1(6):393-7. PubMed ID: 2906631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of selective dopamine-1 receptor activation on intraocular pressure in man.
    Karnezis TA; Murphy MB; Weber RR; Nelson KS; Tripathi BJ; Tripathi RC
    Exp Eye Res; 1988 Nov; 47(5):689-97. PubMed ID: 2904373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine "renal dose" versus fenoldopam mesylate to prevent ischemia-reperfusion injury in renal transplantation.
    Fontana I; Germi MR; Beatini M; Fontana S; Bertocchi M; Porcile E; Saltalamacchia L; Ornis S; Ghinolfi D; Bonifazio L; Valente U
    Transplant Proc; 2005; 37(6):2474-5. PubMed ID: 16182714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of catechol ring fluorination on cardiovascular and renal activities of fenoldopam enantiomers.
    Kinter LB; Mann WA; Weinstock J; Ruffolo RR
    Chirality; 1994; 6(5):446-55. PubMed ID: 7915128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular and renal hemodynamic effects of A-68930 in the conscious dog: a comparison with fenoldopam.
    Christie MI; Smith GW
    J Pharmacol Exp Ther; 1994 Feb; 268(2):565-70. PubMed ID: 7906731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of selective dopamine receptor subtype agonists on cardiac contractility and regional haemodynamics in rats.
    Polakowski JS; Segreti JA; Cox BF; Hsieh GC; Kolasa T; Moreland RB; Brioni JD
    Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):837-41. PubMed ID: 15659045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic renal effects of RS-10085, an ace inhibitor, and fenoldopam, a DA1 agonist, in the rat.
    McClelland DL; Rosenkranz RP
    Proc West Pharmacol Soc; 1988; 31():87-90. PubMed ID: 2905468
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacological evidence for the presence of a peripheral postjunctional D2-like dopamine receptor in rabbit splenic artery.
    Zanzottera D; Ferlenga P; Marchini F; Semeraro C
    Br J Pharmacol; 1998 Feb; 123(4):730-6. PubMed ID: 9517393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine: receptors and clinical applications.
    Goldberg LI
    Clin Physiol Biochem; 1985; 3(2-3):120-6. PubMed ID: 3159532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cultured mesenteric vascular smooth muscle cells express dopamine DA1-receptors.
    Balmforth AJ; Lyall F; Morton JI; Ball SG
    Eur J Pharmacol; 1988 Oct; 155(3):305-8. PubMed ID: 2853067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
    J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of the DA1 receptor agonist fenoldopam in the management of critically ill, transplant, and hypertensive patients.
    Mathur VS
    Rev Cardiovasc Med; 2003; 4 Suppl 1():S35-40. PubMed ID: 12556736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine receptor activation in bovine pinealocyte via a cAMP-dependent transcription pathway.
    Santanavanich C; Ebadi M; Govitrapong P
    J Pineal Res; 2005 Apr; 38(3):170-5. PubMed ID: 15725338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arterial medial necrosis and hemorrhage induced in rats by intravenous infusion of fenoldopam mesylate, a dopaminergic vasodilator.
    Yuhas EM; Morgan DG; Arena E; Kupp RP; Saunders LZ; Lewis HB
    Am J Pathol; 1985 Apr; 119(1):83-91. PubMed ID: 2858975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.